The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | Lung cancer incidence in never-smoking Asian women with a family history of lung cancer
Michael Ou, MD, University of California, San Francisco, CA, shares insights into a prospective trial examining lung cancer incidence in never-smoking Asian women with a family history of lung cancer. 6% of patients were found to have a form of lung cancer, which represents a higher incidence than previously reported for this population. Other factors including second-hand smoke, indoor air pollution and environmental exposure can increase the risk of developing lung cancer, and capturing this information may help in ensuring patients in this population are not missed. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
